Biomarker for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play an vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

  • Prognostic marker
  • Diabetic nephropathy marker
  • Molecular markers for both metabolic syndrome and hypoglycemia response
  • Genetic lifestyle interaction in the development and prevention of diabetes

Related Conference of Biomarker for Diabetes

February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Aix-en-Provence, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Aix-en-Provence, France

Biomarker for Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in